Archive

Ivermectin meta-analysis – the implications

Written by | 27 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the implications of her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=fh5iGkX8Vp4 Dr Lawrie is now trying to make […]

Ivermectin meta-analysis – the findings

Written by | 26 Jan 2021

Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, describes the key findings from her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=WTTqKSYHOM8 The first finding was that […]

Ivermectin meta-analysis – the background

Written by | 25 Jan 2021

IMI interviewed Dr Tess Lawrie, Director of the Evidence-based Medicine Consultancy Ltd, to find out more about her recently-published meta-analysis of ivermectin trials for covid-19. https://www.youtube.com/watch?v=Qnjz0WlDxPc The Evidence-based Medicine […]

Comorbidities and RA – study methodology

Written by | 9 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) used distance matrices to match RA cases to controls with similar medical histories. The […]

Comorbidities and RA – study findings

Written by | 7 Jan 2021

A recent Canadian study examining comorbidities before and after the diagnosis of rheumatoid arthritis (RA) produced a number of interesting findings, Dr Mark Tatangelo, the lead researcher explains. This study […]

Investigating comorbidities and rheumatoid arthritis

Written by | 6 Jan 2021

Rheumatoid arthritis (RA) affects about one percent of the population in the UK and comorbidities are reported to be common. A recent study from Canada was designed to […]

Vaccines – getting the message across

Written by | 28 Nov 2020

Knowing that your GP or pharmacist has had the vaccine can be deeply reassuring, according to Gary Finnegan, health journalist and Editor of Vaccines Today. When communicating about […]

Vaccine confidence and hesitancy

Written by | 27 Nov 2020

Understanding the three Cs of vaccine hesitancy could be the key to ensuring effective uptake of covid-19 vaccines, according to Gary Finnegan, health journalist and Editor of Vaccines […]

Vaccines: where are we now?

Written by | 26 Nov 2020

As planning for a mass covid vaccination campaign gets started, an understanding of vaccines and the factors that drive vaccine confidence will be essential for success. The past […]

Pandemic critical care drug requirements – lessons learned

Written by | 18 Nov 2020

Pharmacist Anita Hogg explains how well Medicines Optimisation Innovation Centre (MOIC) model to estimate the critical care drug requirements during the covid-19 pandemic worked and the lessons learned […]

Estimating pandemic critical care drug requirements

Written by | 17 Nov 2020

Pharmacist Anita Hogg explains how the Medicines Optimisation Innovation Centre (MOIC) in Belfast developed and applied a model to estimate the critical care drug requirements during the covid-19 […]

The MOIC and pandemic critical care drug requirements

Written by | 16 Nov 2020

Pharmacist Anita Hogg explains the work of the Medicines Optimisation Innovation Centre (MOIC) in Belfast and how the Centre helped to ensure reliable provision of critical care drugs […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.